0000000000336452
AUTHOR
Andreas Schneider
showing 16 related works from this author
The Presence of Gestational Diabetes is Associated with Increased Detection of Anti-HLA-class II Antibodies in the Maternal Circulation
2006
Problem Gestational diabetes (GD) may be associated with temporarily reduced immune tolerance toward alloantigens for the time of pregnancy. The aim of this study was to assess anti-HLA-class I and -II antibodies as markers for an aberrant immunostimulation in women with GD. Method of study The percentage of anti-HLA-class I and -II antibodies was estimated in women with GD, normal term delivery and fetal distress, which was confirmed by demonstrating low cord blood pH for this patient group. These antibodies may cross the placental barrier and cause interleukin-6 (IL-6) release from fetal monocytes by cross-linking monocytes with antibody-loaded cells. Therefore we estimated the percentage…
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.
2017
BackgroundIdarucizumab is a monoclonal antibody fragment with high affinity for dabigatran that reverses its anticoagulant effects within minutes. It may exhibit the potential for patients under dabigatran therapy suffering ischemic stroke to regain eligibility for thrombolysis with rt-PA and may inhibit lesion growth in patients with intracerebral hemorrhage on dabigatran.AimsTo provide insights into the clinical use of idarucizumab in patients under effective dabigatran anticoagulation presenting with signs of ischemic stroke or intracranial hemorrhage.MethodsRetrospective data collected from German neurological/neurosurgical departments administering idarucizumab following product launch…
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 cases
2020
Background Idarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Thereby, patients with acute ischemic stroke who are on dabigatran treatment may become eligible for thrombolysis with recombinant tissue-type plasminogen activator (rt-PA). In patients on dabigatran with intracerebral hemorrhage idarucizumab could prevent lesion growth. Aims To provide insights into the clinical use of idarucizumab in patients under effective dabigatran anticoagulation presenting with signs of acute ischemic stroke or intracranial hemorrhage. Methods Retrospective data collected from German neurological/neurosurgical departments ad…
Chiral self-sorting behaviour of [2.2]paracyclophane-based bis(pyridine) ligands
2019
Two constitutionally isomeric chiral bis(pyridine) ligands based on planar chiral 4,15-difunctionalized [2.2]paracyclophanes were synthesized, the respective enantiomers were separated via HPLC on a chiral stationary phase, and their self-assembly behaviour upon coordination to palladium(ii) ions was studied with regard to chiral self-sorting effects. As proven by NMR spectroscopy, mass spectrometry, CD spectroscopy, UV-Vis spectroscopy and X-ray crystallography both ligands form the expected dinuclear complexes upon coordination to cis-protected di- or tetravalent palladium(ii) ions, respectively, however, with distinct differences concerning their chiral self-sorting ability. peerReviewed
Influencing the Self‐Sorting Behavior of [2.2]Paracyclophane‐Based Ligands by Introducing Isostructural Binding Motifs
2020
Abstract Two isostructural ligands with either nitrile (Lnit) or isonitrile (Liso) moieties directly connected to a [2.2]paracyclophane backbone with pseudo‐meta substitution pattern have been synthesized. The ligand itself (Lnit) or its precursors (Liso) were resolved by HPLC on a chiral stationary phase and the absolute configuration of the isolated enantiomers was assigned by XRD analysis and/or by comparison of quantum‐chemical simulated and experimental electronic circular dichroism (ECD) spectra. Surprisingly, the resulting metallosupramolecular aggregates formed in solution upon coordination of [(dppp)Pd(OTf)2] differ in their composition: whereas Lnit forms dinuclear complexes, Liso…
Subcomponent self‐assembly of a cyclic tetranuclear Fe(II) helicate in a highly diastereoselective self‐sorting manner
2019
Abstract An enantiomerically pure diamine based on the 4,15‐difunctionalized [2.2]paracyclophane scaffold and 2‐formylpyridine self‐assemble into an optically pure cyclic metallosupramolecular Fe4L6 helicate upon mixing with iron(II) ions in a diastereoselective subcomponent self‐assembly process. The cyclic assembly results from steric strain that prevents the formation of a smaller linear dinuclear triple‐stranded helicate, and hence, leads to the larger strain‐free assembly that fulfils the maximum occupancy rule. Interestingly, use of the racemic diamine also leads to a racemic mixture of the homochiral cyclic helicates as the major product in a highly diastereoselective narcissistic ch…
Influencing the self‐sorting behavior of [2.2]paracyclophane based ligands by introducing isostructural binding motifs
2020
Two isostructural ligands with either nitrile ( L nit ) or isonitrile ( L iso ) moieties directly connected to a [2.2]paracyclophane backbone with pseudo‐meta substitution pattern have been synthesized. The ligand itself ( L nit ) or its precursors ( L iso ) were resolved via HPLC on a chiral stationary phase and the absolute configuration of the isolated enantiomers was assigned by XRD analysis and/or by comparison of quantum‐chemical simulated and experimental ECD‐spectra. Surprisingly, the resulting metallosupramolecular aggregates formed in solution upon coordination of [(dppp)Pd(OTf) 2 ] differ in their composition: whereas L nit forms dinuclear complexes L iso exclusively forms trinuc…
CCDC 1919439: Experimental Crystal Structure Determination
2019
Related Article: Jana Anhäuser, Rakesh Puttreddy, Lukas Glanz, Andreas Schneider, Marianne Engeser, Kari Rissanen, Arne Lützen|2019|Chem.-Eur.J.|25|12294|doi:10.1002/chem.201903164
CCDC 1824417: Experimental Crystal Structure Determination
2020
Related Article: Lucia Volbach, Niklas Struch, Fabian Bohle, Filip Topić, Gregor Schnakenburg, Andreas Schneider, Kari Rissanen, Stefan Grimme, Arne Lützen|2020|Chem.-Eur.J.|26|3335|doi:10.1002/chem.201905070
CCDC 1824416: Experimental Crystal Structure Determination
2020
Related Article: Lucia Volbach, Niklas Struch, Fabian Bohle, Filip Topić, Gregor Schnakenburg, Andreas Schneider, Kari Rissanen, Stefan Grimme, Arne Lützen|2020|Chem.-Eur.J.|26|3335|doi:10.1002/chem.201905070
CCDC 1955599: Experimental Crystal Structure Determination
2020
Related Article: Lucia Volbach, Niklas Struch, Fabian Bohle, Filip Topić, Gregor Schnakenburg, Andreas Schneider, Kari Rissanen, Stefan Grimme, Arne Lützen|2020|Chem.-Eur.J.|26|3335|doi:10.1002/chem.201905070
CCDC 1919442: Experimental Crystal Structure Determination
2019
Related Article: Jana Anhäuser, Rakesh Puttreddy, Lukas Glanz, Andreas Schneider, Marianne Engeser, Kari Rissanen, Arne Lützen|2019|Chem.-Eur.J.|25|12294|doi:10.1002/chem.201903164
CCDC 1919441: Experimental Crystal Structure Determination
2019
Related Article: Jana Anhäuser, Rakesh Puttreddy, Lukas Glanz, Andreas Schneider, Marianne Engeser, Kari Rissanen, Arne Lützen|2019|Chem.-Eur.J.|25|12294|doi:10.1002/chem.201903164
CCDC 1919440: Experimental Crystal Structure Determination
2019
Related Article: Jana Anhäuser, Rakesh Puttreddy, Lukas Glanz, Andreas Schneider, Marianne Engeser, Kari Rissanen, Arne Lützen|2019|Chem.-Eur.J.|25|12294|doi:10.1002/chem.201903164
CCDC 1955601: Experimental Crystal Structure Determination
2020
Related Article: Lucia Volbach, Niklas Struch, Fabian Bohle, Filip Topić, Gregor Schnakenburg, Andreas Schneider, Kari Rissanen, Stefan Grimme, Arne Lützen|2020|Chem.-Eur.J.|26|3335|doi:10.1002/chem.201905070
CCDC 1955600: Experimental Crystal Structure Determination
2020
Related Article: Lucia Volbach, Niklas Struch, Fabian Bohle, Filip Topić, Gregor Schnakenburg, Andreas Schneider, Kari Rissanen, Stefan Grimme, Arne Lützen|2020|Chem.-Eur.J.|26|3335|doi:10.1002/chem.201905070